[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"cervical-cancer-early-detection\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:cervical-cancer-early-detection":146},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,46,75,104],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":30,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":40,"leadSponsor":42,"locationsCount":45},"100619937",false,"NCT07351110","Improving Cervical Cancer Prevention Among Women Living With Chronic Conditions.","Improving Cervical Cancer Prevention Among Women Living With Chronic Conditions. Aim 3: Assess the Feasibility and Acceptability of the PINPOINT Intervention.","PINPOINT","Inclusion Criteria:\n\nThe following eligibility criteria will be used to determine inclusion into the study:\n\n1. Using the American Cancer Society (ACS) screening recommendations, adults aged over the age of 25 will be eligible\n2. Active UF Internal Medicine patient and has had an appointment in the last 2 months.\n3. Assigned sex at birth is female\n4. Have Obesity or Type 2 Diabetes\n5. Not currently pregnant (self-report)\n6. Have not given birth in the prior 12 weeks\n7. No previous history of cervical cancer\n8. No previous history of a hysterectomy\n9. Have not undergone cancer screening in the past 3 years or more\n10. Reside in the UFHCI Catchment Area (Alachua, Baker, Bradford, Citrus, Clay, Columbia, Dixie, Gadsden, Gilchrist, Hamilton, Jefferson, Lafayette, Lake, Leon, Levy, Madison, Marion, Putnam, Sumter, Suwannee, Taylor, UnioF1n, or Wakulla County).\n11. Have a mobile phone or access to a mobile phone that can be used to receive messages, or a valid email address.\n12. Are not currently scheduled to receive cervical cancer screening via clinician sampling (pap smear).\n\nExclusion Criteria:\n\n* Previous history of cervical cancer\n* Total hysterectomy\n* Pregnant",true,"FEMALE","25 Years",{"count":20,"type":21},20,"ESTIMATED","INTERVENTIONAL",[24],"NA","Our overarching goal is to adapt and test the PINPOINT intervention -PatIent Navigation for the Prevention of CervIcal CaNcer inTervention. We will test the PINPOINT intervention among patients with high-risk profiles for cervical cancer who do not meet the recommended screening for cervical cancer.",[27,28,29],"Diabetes","Cervical Cancer (Early Detection)","Obesity & Overweight",[31,32,33],"cervical cancer screening","self-collection","self-sampling","RECRUITING","2026-06-26",{"date":37,"type":38},"2026-06-30","ACTUAL",{"date":37,"type":21},{"date":41,"type":21},"2027-03-24",{"name":43,"class":44},"University of Florida","OTHER",1,{"id":47,"slug":4,"hasResults":10,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":4,"eligibilityCriteria":51,"healthyVolunteers":10,"sex":17,"minAge":18,"maxAge":52,"enrollmentInfo":53,"targetDuration":4,"studyType":55,"phases":4,"briefSummary":56,"conditions":57,"keywords":59,"overallStatus":65,"whyStopped":4,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":4},"100640087","NCT07606677","Peripheral Blood CyTOF Immune Model for Cervical Lesion Detection in HPV16\u002F18+ Women","Mass Cytometry-based Peripheral Blood Immune Model for Accurate Detection of Cervical Lesions in HPV16\u002F18-positive Women: a Multicenter Study","Inclusion Criteria:\n\n* Availability of cervical cytology results\n* Consent to colposcopy and cervical biopsy\n* Signed informed consent\n\nExclusion Criteria:\n\n* Confirmed diagnosis of CIN2 or worse\n* Prior cervical ablation, cervical conization, chemoradiotherapy, or immunotherapy\n* Other malignancy within the past 2 years not in complete remission\n* Presence of other systemic immune disease or active infection\n* Pregnancy or lactation\n* Inability to comply with follow-up and examinations\n* Inability to comply with study procedures, restrictions, and requirements, as determined by the investigator","65 Years",{"count":54,"type":21},1465,"OBSERVATIONAL","This prospective, multicenter cohort study will recruit eligible HPV16\u002F18-positive women from three tertiary hospitals in China. Peripheral blood samples and clinical data (cytology, HPV genotyping, colposcopy-directed biopsy) will be collected, followed by standardized mass cytometry (CyTOF) to develop and evaluate an immune model across cervical lesion grades.",[58,28],"CIN 2\u002F3",[60,61,62,63,64],"cervical cancer","Cervical Intraepithelial Neoplasia","HPV16\u002F18","Mass cytometry","Immune model","NOT_YET_RECRUITING","2026-05-18",{"date":68,"type":38},"2026-05-26",{"date":70,"type":21},"2026-05-15",{"date":72,"type":21},"2028-03-31",{"name":74,"class":44},"Women's Hospital School Of Medicine Zhejiang University",{"id":76,"slug":4,"hasResults":10,"nctId":77,"briefTitle":78,"officialTitle":79,"acronym":4,"eligibilityCriteria":80,"healthyVolunteers":16,"sex":17,"minAge":81,"maxAge":52,"enrollmentInfo":82,"targetDuration":4,"studyType":22,"phases":84,"briefSummary":85,"conditions":86,"keywords":91,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":95,"lastUpdatePostDateStruct":96,"startDateStruct":98,"completionDateStruct":100,"leadSponsor":102,"locationsCount":45},"100619536","NCT07345897","Emergency Department-based Cervical Cancer Screening Through Self-sampling","Advancing Cervical Cancer Screening Through Emergency Department-based Self-Sampling","Inclusion Criteria:\n\n* Cisgender women and transgender\u002Fnon-binary individuals with a cervix,\n* Age 30 - 65 years, and demonstrating decisional capacity to consent to participate with no known exclusion criteria present.\n\nExclusion Criteria:\n\n* Past hysterectomy with cervical removal\n* Known infection with HIV (as screening recommendations for people with HIV differ from the general population)\n* Inability to consent (e.g., lacking decisional capacity, intoxicated, or in distress)\n* Current pregnancy or in the three months after giving birth\n* Use of vaginal ovules, creams or washes, vaginal contraceptives or condoms within past 3 days\n* Sexual intercourse or transvaginal ultrasound scans or gynecological examinations within past 2 days","30 Years",{"count":83,"type":21},200,[24],"This project will compare the uptake of cervical cancer screening through ED HPV sampling among patients presenting to the ED.",[87,88,89,90,28],"HPV","HPV Associated Cancers","HPV Cancers","Cervical Cancer Screening",[92,93,87,94],"HPV Screening","Cervical cancer screening","Cervical cancer","2026-04-27",{"date":97,"type":38},"2026-05-04",{"date":99,"type":38},"2026-02-13",{"date":101,"type":21},"2028-01",{"name":103,"class":44},"University of Rochester",{"id":105,"slug":4,"hasResults":10,"nctId":106,"briefTitle":107,"officialTitle":107,"acronym":108,"eligibilityCriteria":109,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":110,"targetDuration":4,"studyType":22,"phases":112,"briefSummary":113,"conditions":114,"keywords":123,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":136,"lastUpdatePostDateStruct":137,"startDateStruct":139,"completionDateStruct":141,"leadSponsor":143,"locationsCount":5},"100614592","NCT07281599","Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer","EQUIP","Inclusion Criteria:\n\n* You are 25 years old or older and have an intact cervix.\n* You were referred for a colposcopy after an abnormal Pap or HPV screen.\n* Your periods come regularly-about every 21-35 days.\n* You own a smartphone, have an email address, and can read the Qvin app instructions in English.\n* You are willing to sign the consent form (electronically).\n* You agree to use a condom for any vaginal intercourse or shared penetrative toy use from Q-Pad collection until the colposcopy visit if engaging with a new sexual partner during this period.\n\nExclusion Criteria:\n\n* You are pregnant or think you might be.\n* You are unwilling or unable to use the two Q-Pads and mail them back (mailing costs are covered).\n* You had treatment for cervical pre-cancer (CIN2+)-such as LEEP, cone, or ablation-within the last 12 months.\n* You have already joined this study or are in another cervical-screening \u002F HPV study right now.",{"count":111,"type":21},450,[24],"The EQUIP Study is testing whether high-risk human papillomavirus (hrHPV), the virus that causes most cervical cancers, can be accurately detected from menstrual blood collected at home. People who have been referred for colposcopy after an abnormal Pap or hrHPV test will use the Q-Pad Kit during their period to collect menstrual samples on a special menstrual pad and mail them to a central laboratory for hrHPV testing.\n\nThe same participants will have a standard cervical sample collected for routine hrHPV testing and will undergo colposcopy as part of their usual care. By comparing hrHPV results from menstrual samples with results from cervical samples and biopsy findings, the study will evaluate how well the Q-Pad hrHPV Test System detects cervical precancer and will also assess how easy and acceptable it is for participants to use this at-home collection method.",[115,116,117,90,118,28,87,119,120,121,122],"HPV Infection","HPV 16 Infection","High Risk HPV","Cervical Cancer Cin Grade","HPV (Human Papillomavirus)-Associated","HPV DNA","HPV Infections","Screening Test",[124,125,126,127,31,128,129,130,131,132,87,133,134,135],"Q-Pad","Self-sampling","Self-collection","self-collect","menstural blood","Sexually Transmitted Diseases, Viral","Sexually Transmitted Diseases","Genital Diseases","Papillomavirus Infections","high risk HPV","pap smear","at-home collection","2026-01-29",{"date":138,"type":38},"2026-02-02",{"date":140,"type":38},"2025-12-01",{"date":142,"type":21},"2027-03",{"name":144,"class":145},"Qurasense","INDUSTRY",""]